KBC Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.9M Sell
108,166
-5,475
-5% -$1.48M 0.07% 224
2025
Q4
$28.5M Buy
113,641
+7,151
+7% +$1.9M 0.07% 224
2025
Q3
$30.6M Buy
106,490
+10
+0% +$2.68K 0.07% 214
2025
Q2
$28M Buy
106,480
+2,420
+2% +$589K 0.08% 229
2025
Q1
$24.2M Buy
104,060
+2,093
+2% +$508K 0.08% 246
2024
Q4
$23.4M Buy
101,967
+7,159
+8% +$1.64M 0.06% 256
2024
Q3
$21.2M Sell
94,808
-4,154
-4% -$913K 0.06% 263
2024
Q2
$20.1M Sell
98,962
-3,498
-3% -$712K 0.06% 240
2024
Q1
$22.4M Sell
102,460
-5,607
-5% -$1.24M 0.07% 235
2023
Q4
$24.6M Buy
108,067
+569
+0.5% +$120K 0.09% 229
2023
Q3
$21.6M Sell
107,498
-19,418
-15% -$4.1M 0.09% 228
2023
Q2
$26.3M Sell
126,916
-52,143
-29% -$10.1M 0.11% 183
2023
Q1
$35.3M Buy
179,059
+28,653
+19% +$5.9M 0.15% 142
2022
Q4
$30.4M Sell
150,406
-850
-0.6% -$166K 0.15% 157
2022
Q3
$26.6M Buy
151,256
+16,574
+12% +$3.39M 0.14% 162
2022
Q2
$27.1M Sell
134,682
-24,401
-15% -$5.2M 0.14% 179
2022
Q1
$36M Sell
159,083
-116,318
-42% -$27.4M 0.14% 172
2021
Q4
$74.3M Buy
275,401
+9,412
+4% +$2.33M 0.25% 104
2021
Q3
$64.3M Sell
265,989
-280,968
-51% -$70.8M 0.24% 101
2021
Q2
$130M Sell
546,957
-72,228
-12% -$16.5M 0.23% 104
2021
Q1
$136M Buy
619,185
+3,243
+0.5% +$651K 0.27% 82
2020
Q4
$592M Buy
615,942
+221,230
+56% +$38.2M 0.25% 97
2020
Q3
$63.8M Buy
394,712
+137,989
+54% +$21.9M 0.19% 126
2020
Q2
$36.6M Buy
256,723
+144,189
+128% +$19.9M 0.12% 176
2020
Q1
$12.2M Sell
112,534
-32,722
-23% -$4.71M 0.1% 211
2019
Q4
$21.1M Sell
145,256
-3,100
-2% -$448K 0.13% 190
2019
Q3
$21.4M Buy
148,356
+46,031
+45% +$6.72M 0.16% 158
2019
Q2
$15.2M Buy
102,325
+1,133
+1% +$158K 0.12% 213
2019
Q1
$13.3M Sell
101,192
-11,574
-10% -$1.43M 0.11% 232
2018
Q4
$12.2M Buy
112,766
+44,151
+64% +$5.91M 0.14% 192
2018
Q3
$10.2M Buy
68,615
+19,261
+39% +$2.93M 0.08% 290
2018
Q2
$7.61M Sell
49,354
-3,935
-7% -$594K 0.07% 334
2018
Q1
$7.41M Sell
53,289
-17,614
-25% -$2.59M 0.07% 311
2017
Q4
$9.72M Sell
70,903
-41,743
-37% -$5.52M 0.08% 284
2017
Q3
$14.6M Sell
112,646
-29,533
-21% -$3.94M 0.13% 186
2017
Q2
$18.8M Buy
142,179
+14,551
+11% +$1.78M 0.18% 144
2017
Q1
$15.7M Buy
127,628
+65,388
+105% +$7.74M 0.14% 178
2016
Q4
$6.87M Buy
62,240
+21,953
+54% +$2.44M 0.07% 333
2016
Q3
$4.76M Buy
40,287
+8,835
+28% +$1.04M 0.06% 349
2016
Q2
$3.52M Buy
31,452
+19,637
+166% +$2.11M 0.05% 397
2016
Q1
$1.19M Sell
11,815
-1,079
-8% -$103K 0.02% 607
2015
Q4
$1.37M Buy
12,894
+1,673
+15% +$173K 0.03% 547
2015
Q3
$1.05M Sell
11,221
-307
-3% -$31.8K 0.02% 587
2015
Q2
$1.2M Buy
11,528
+896
+8% +$93.3K 0.02% 690
2015
Q1
$1.15M Buy
10,632
+1,482
+16% +$152K 0.01% 696
2014
Q4
$848K Buy
9,150
+3,084
+51% +$272K 0.01% 796
2014
Q3
$530K Sell
6,066
-7,483
-55% -$676K 0.02% 729
2014
Q2
$1.19M Buy
13,549
+1,910
+16% +$165K 0.01% 718
2014
Q1
$982K Sell
11,639
-10,795
-48% -$861K 0.02% 657
2013
Q4
$1.76M Sell
22,434
-676
-3% -$57.7K 0.03% 539
2013
Q3
$1.97M Sell
23,110
-892
-4% -$75.1K 0.03% 505
2013
Q2
$2.06M Buy
+24,002
New +$1.99M 0.04% 487

Other funds holding LH

KBC Group's LH Position: Q1 2026 in Review

KBC Group reduced its Labcorp (LH) stake by 4.8% in Q1 2026, selling an estimated $1.48M and leaving 108,166 shares worth $28.9M. The position accounts for 0.07% of the portfolio, ranked #224.

KBC Group first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $592M in Q4 2020. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • KBC Group held 108,166 shares of Labcorp worth $28.9M as of Q1 2026.
  • KBC Group sold 5,475 Labcorp shares in Q1 2026, an estimated $1.48M.
  • Labcorp made up 0.07% of KBC Group's portfolio in Q1 2026, its #224 holding.
  • KBC Group first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's Labcorp position peaked at $592M in Q4 2020.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.